NVDA News 18.56 Nvidia Corp (NVDA)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nvidia Corp (NVDA) 18.56 $NVDA

NVIDIA's Shield Has Quietly Become a Mobile Gaming Powerhouse
Timothy Green, The Motley Fool - Motley Fool - Thu Apr 17, 12:00PM CDT
Back when NVIDIA first announced the Shield handheld gaming device at the beginning of 2013, I was highly skeptical. It seemed that the Shield tried to fill a gap that didn't really exist, and that competing against the phones and tablets that...

Side-Step the Selling With These 5 Big-Name Trades
at The Street - Thu Apr 17, 10:27AM CDT
Here's a technical look at five high-volume stocks to trade this week.

Will NVIDIA Corporation's Tegra K1 Appear in Mobile Devices Soon?
Ashraf Eassa, The Motley Fool - Motley Fool - Wed Apr 16, 6:30PM CDT
At CES 2014, NVIDIA announced its next-generation mobile processor known as the Tegra K1. The K1 is actually set to hit in two flavors: a 32-bit version using a 4+1 ARM Cortex A15 configuration, and a 64-bit version using dual NVIDIA-designed...

Advanced Micro Devices, Inc. Earnings: Will the Huge Surge Last?
Dan Caplinger, The Motley Fool - Motley Fool - Wed Apr 16, 1:00PM CDT
On Thursday, Advanced Micro Devices will release its quarterly report, and shareholders have high hopes that the chipmaker will be able to build on its huge growth from the previous quarter on the back of growth in specialty game-console chip...

Embrace Volatility: Buy Google and Chipotle, Sell AMD
at The Street - Wed Apr 16, 5:00AM CDT
Playing earnings correctly can sometimes be the difference between a passing and a failing portfolio.

AMD Bests NVIDIA With the Radeon 295X2
Timothy Green, The Motley Fool - Motley Fool - Tue Apr 15, 9:15AM CDT
Advanced Micro Devices has been losing discrete GPU market share to rival NVIDIA for the past few years. With NVIDIA continually beating AMD in the high end of the market, the former has been able to claim a roughly 65% share of discrete GPU...

How NVIDIA Is Helping Adobe Power Our Creative Future
Steve Symington, The Motley Fool - Motley Fool - Mon Apr 14, 7:05PM CDT
NVIDIA's Quadro and Tesla GPUs are the driving forces behind Adobe Creative Cloud. Source: NVIDIA. At the 2014 NAB Show in Vegas earlier this month, Adobe showcased some thrilling enhancements to the video apps in its Adobe Creative Cloud...

Intel Corporation Earnings: Will Mobile Finally Bring Growth?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 14, 12:00PM CDT
On Tuesday, Intel will release its quarterly report, and investors have finally started to feel some optimism about the stock's future direction. Even though Qualcomm and NVIDIA initially beat Intel to the mobile-chip party, Intel has put...

NVIDIA Announces Upcoming Event for Financial Community
Marketwire - Fri Apr 11, 4:00PM CDT
NVIDIA will present at the following upcoming conference for the financial community:

Nvidia Has Returned 11.8% Since SmarTrend Recommendation (NVDA)
Comtex SmarTrend(R) - Fri Apr 11, 10:14AM CDT
SmarTrend identified an Uptrend for Nvidia (NASDAQ:NVDA) on January 8th, 2014 at $16.29. In approximately 3 months, Nvidia has returned 11.85% as of today's recent price of $18.22.

Nvidia (NVDA) Crosses Pivot Point Support at $18.65
Comtex SmarTrend(R) - Thu Apr 10, 12:30PM CDT
Shares of Nvidia (NASDAQ:NVDA) have bearishly opened below the pivot of $18.88 today and have reached the first support level of $18.65. Analysts will be watching for a cross of the next downside pivot targets of $18.46 and $18.04.

Why Your Next Car Might Be Powered by NVIDIA
Timothy Green, The Motley Fool - Motley Fool - Thu Apr 10, 10:00AM CDT
The automobile will likely be the next big battleground for tech companies, with the in-car display ripe for disruption. Compared to smartphones, in-car "infotainment" systems today are as dumb as bricks, and the long development cycles ensure that...

Rambus Unit & Fairchild Ink Licensing Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 12:00PM CDT
Recently, Rambus Inc.'s division, Cryptography Research, Inc. signed a patent licensing agreement with Fairchild Semiconductor Corp. for an undisclosed sum.

Financial Results Release Dates, Financing Facilities, and Collaborations - Analyst Notes on Micron, SolarCity, NVIDIA, NXP, and Lam Research
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Micron Technology, Inc. (NASDAQ: MU), SolarCity Corporation (NASDAQ: SCTY), NVIDIA Corporation (NASDAQ: NVDA), NXP Semiconductors N.V. (NASDAQ: NXPI), and Lam Research Corporation (NASDAQ: LRCX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Qualcomm Enhances Snapdragon Processors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 1:50PM CDT
Qualcomm Incorporated revealed that it is working toward improving the performance of its high-end Snapdragon processors.

Forget AMD: Here's Why NVIDIA Will Continue to Dominate the PC Gaming Market
Timothy Green, The Motley Fool - Motley Fool - Tue Apr 08, 10:20AM CDT
Shares of graphics chip company NVIDIA have soared over the past year, rising about 50%, with sales of the company's high-end gaming GPUs making up for a weak PC market. The rise of mobile gaming and the new generation of game consoles haven't...

Critical Alerts For JPMorgan, Amgen, Yahoo, NVIDIA, and Anheuser-Busch InBev Released By InvestorsObserver
PR Newswire - Tue Apr 08, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for JPM, AMGN, YHOO, NVDA, and BUD.

Stock Price Updates, New App Launches, and Strategic Partnerships - Analyst Notes on Applied Materials, Qihoo 360, Splunk, ServiceNow, and NVIDIA
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Applied Materials, Inc. (NASDAQ: AMAT), Qihoo 360 Technology Co Ltd (NYSE: QIHU), Splunk Inc. (NASDAQ: SPLK), ServiceNow, Inc. (NYSE: NOW), and NVIDIA Corporation (NASDAQ: NVDA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Technical Data on Active Stocks -- Research on Frontier Communications, Xerox, Arch Coal, and NVIDIA
PR Newswire - Mon Apr 07, 7:17AM CDT
The US markets saw a negative sentiment on Friday, April 04, 2014, with the Dow Jones Industrial Average closing at 16,412.71, down 0.96%, the NASDAQ Composite ending at 4,127.73, down 2.60%, and the S&P 500 finishing the session 1.25% lower at 1,865.09. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Frontier Communications Corp. (NASDAQ: FTR), Xerox Corp. (NYSE: XRX), Arch Coal Inc. (NYSE: ACI) and NVIDIA Corp. (NASDAQ: NVDA). Free technical research on FTR, XRX, ACI and NVDA can be downloaded upon signing up at:

What's Next for NVIDIA's Modems?
Ashraf Eassa, The Motley Fool - Motley Fool - Sun Apr 06, 3:30PM CDT
At NVIDIA 's GPU Technology Conference, NVIDIA CEO Jen-Hsun Huang made it quite clear that the company had no further intentions of competing in the highly integrated, cost-sensitive mainstream smartphone applications processor market. With...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading